RAZOR Act

The RAZOR Act, also known as Bill 118 hr 7083, is a piece of legislation introduced in the US Congress that aims to address the issue of rising prescription drug prices. The bill focuses on increasing transparency in the pharmaceutical industry by requiring drug manufacturers to disclose the costs associated with producing and marketing their medications.

Under the RAZOR Act, pharmaceutical companies would be required to provide detailed information on the expenses related to research and development, manufacturing, and marketing of their drugs. This information would be made publicly available in order to increase accountability and help consumers better understand the factors contributing to high drug prices.

Additionally, the bill includes provisions to promote competition in the pharmaceutical market by allowing for the importation of cheaper prescription drugs from other countries. This measure is intended to lower costs for consumers and increase access to affordable medications. Overall, the RAZOR Act seeks to address the issue of rising prescription drug prices by increasing transparency in the pharmaceutical industry and promoting competition to lower costs for consumers. The bill is currently being debated in Congress and has garnered support from both Democrats and Republicans who are concerned about the affordability of healthcare in the United States.